Ontario Printed Educational Message trial (OPEM): changing physician decision making towards more evidence based choices

Not Applicable

Completed

• Conditions: Diabetes, hypertension; Nutritional, Metabolic, Endocrine; Diabetes

• Registration Number: ISRCTN72772651
• Lead Sponsor: Institute for Clinical Evaluative Sciences - Toronto (Canada)

Brief Summary

2007 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/18039362 process evaluation protocol 2007 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/18039361 protocol 2007 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/18039363 sub-trial protocol 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25098442 diabetic retinopathy results 2014 Results article in http://www.ncbi.nlm.nih.gov/pubmed/25098587 diabetic retinopathy results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27619339 hypertension results 2016 Results article in http://www.ncbi.nlm.nih.gov/pubmed/27640126 hypertension results 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34895165/ (added 14/12/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-07-21
• Study Completion: 2006-07-01
• Last Update Posted: 27 December 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 5547

Inclusion Criteria

5547 actively practicing family (FP) and general practitioners (GP) in Ontario (~25 years and above, either sex) that have more than 100 patients over 65 years of age in fee for service practice with greater $50,000 billings to OHIP in 2003, randomised each time for three mail-outs of PEMs - the Printed Educational Materials

Exclusion Criteria

Physicians who have elected not to receive 'informed', a newsletter on evidence based practice out of the Institute for Clinical Evaluative Sciences (ICES)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Three trials:<br>1. Proportion of new hypertensives on diuretics<br>2. Proportion of diabetics who receive retinal screening<br>3. Proportion of diabetics who receive lipid lowering and antihypertensive medication and an ACE inhibitor<br><br>All measured from routinely collected health insurance and administrative information: OHRI, ODB, CIHI

Secondary Outcome Measures

Name	Time	Method
o secondary outcome measures